Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Immunol Immunopathol ; 81(2): 122-8, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8906742

RESUMO

In this paper, we demonstrated that the production of PGE2 by CD8+ T lymphocytes through muscarinic cholinergic receptor (mAChR) activation of lymphocytes from mice acutely infected with nonlethal Trypanosoma cruzi CA-1 strain could enhance resistance to infection. Treatment in vivo with either atropine or cyclooxygenase inhibitors enhanced mortality rates and parasitemia of mice infected with T. cruzi CA-1 strain. The mechanism by which CD8+ T lymphocytes released PGE2 appears to involve the activation of the cells by circulating IgG present in mice infected with T. cruzi CA-1 strain. Binding of these antibodies to mAChR on CD8+ T lymphocytes triggered the release of large amounts of PGE2. The results point to a role of serum antibodies against mAChR in the protection of T. cruzi infection. The prostanoid acting as an immunomodulator contributed to the maintenance of the chronic course of experimental Chagas disease.


Assuntos
Adjuvantes Imunológicos/farmacologia , Linfócitos T CD8-Positivos/química , Doença de Chagas/imunologia , Dinoprostona/farmacologia , Receptores Colinérgicos/metabolismo , Receptores Muscarínicos/metabolismo , Animais , Atropina/farmacologia , Membrana Celular/parasitologia , Doença de Chagas/sangue , Dinoprostona/sangue , Imunidade Inata , Imunoglobulina G/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Antagonistas Muscarínicos/farmacologia , Receptores Colinérgicos/imunologia , Receptores Muscarínicos/imunologia , Linfócitos T/metabolismo , Trypanosoma cruzi/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...